Novel Clinical Trial Designs for Treatment of Ductal Carcinoma In Situ of the Breast with Trastuzumab (Herceptin)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Novel Clinical Trial Designs for Treatment of Ductal Carcinoma In Situ of the Breast with Trastuzumab (Herceptin)

Published:2007-01 Issue:1 Volume:13 Page:72-75
ISSN:1075-122X
Container-title:The Breast Journal
language:en
Short-container-title:Breast Journal

Author:

Gonzalez Ricardo J.,Buzdar Aman U.,Fraser Symmans W.,Yen Tina W.,Broglio Kristine R.,Lucci Anthony,Esteva Francisco J.,Yin Guosheng,Kuerer Henry M.

Publisher

Hindawi Limited

Subject

Oncology,Surgery,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1524-4741.2006.00366.x/fullpdf

Reference18 articles.

1. Continued local recurrence of carcinoma 15–25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy

2. Trends in the Treatment of Ductal Carcinoma In Situ of the Breast

3. Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial

4. Applying the neoadjuvant paradigm to ductal carcinoma in situ

5. Neoadjuvant hormonal therapy for ductal carcinoma in situ: Trial design and preliminary results

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DCIS in BRCA1 and BRCA2 mutation carriers: prevalence, phenotype, and expression of oncodrivers C-MET and HER3;Journal of Translational Medicine;2015-10-24

2. Increased Likelihood of Mastectomy in Human Epidermal Growth Factor Receptor 2-positive Ductal Carcinoma In Situ;The American Surgeon;2014-10

3. Human epidermal growth factor receptor 2-positive microinvasive breast carcinoma with a highly aggressive course: a case report;BMC Research Notes;2014-05-31

4. Novel Methods and Tracers for Breast Cancer Imaging;Seminars in Nuclear Medicine;2013-07

5. Molecular Pathology and Molecular Markers of Ductal Carcinoma in-situ;Current Cancer Therapy Reviews;2012-08-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3